We represented AnovoRx Holdings, Inc., a leading provider of specialty pharmacy services and customized treatment and support programs that address the unique needs of patients with certain complex and chronic diseases, in its minority investment from TPG Growth, a middle market and growth equity platform of alternative asset firm. Terms of the transaction were not disclosed.